What's new in Interventional Cardiology

In patients with non-left main coronary bifurcation lesions treated with provisional stenting and POT, the KISS randomised trial compares a strategy of no side branch intervention versus systematic side branch treatment.

In patients with moderate-to-severe calcified coronary lesions, ICARE OFDI evaluates IVL versus rotational atherectomy as lesion preparation strategies, with OFDI-based assessment of stent results.

At EuroPCR 2026, two awards highlighted innovation and emerging talent in interventional cardiology. Lene Andreasen received the Michele Pighi Young Investigator Award for her research on coronary bifurcation PCI from the OCTOBER trial, while Susheel Kodali and the Nyra Medical team were honoured with the Jon...

This one-of-a-kind academy offers independent, cutting-edge training pathways for ambitious interventionalists who have been in practice for a few years and are looking to grow - both personally and professionally. Two recurrent high-level one-year tracks on coronary interventions and TAVI are already underway, with further opportunities forecast for...

These trials were selected for their design, results, and potential to impact clinical practice: discover the key findings of an IPD meta-analysis on coronary revascularisation in TAVI patients, a long-term comparison of PCI vs. CABG for left main disease, and a study on LAA closure vs....

The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.

The first and only peer-reviewed case report journal dedicated entirely to interventional cardiovascular medicine: EuroIntervention Case Reports.

PCR has developed an independent educational framework to facilitate the worldwide training of the next generation of interventional cardiologists in host centres that are renowned for their expertise. This new initiative supports practitioners at all stages of their career – promoting professional growth, geographical mobility and cultural exchange.

The EuroPCR 2026 Course Directors set the stage for a programme focused on sharing experiences, advancing practice, and improving patient care, with a renewed emphasis on learning from complications and keeping patients at the heart of everything we do.

ViTAL® (Visionary Transformative Adult Learning) was born from a simple but demanding conviction: experienced professionals continue to learn best through interaction, reflection, shared experience, and active participation.